Frenelle Pharma Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$1.22M
- Investors
-
5
Frenelle Pharma General Information
Description
Operator of a clinical-stage pharmaceutical company intended to work to improve the lives of patients by creating injectable drugs utilizing our micro-suspension, sustained-release platform technology. The company's lead investigational drug product is a novel formulation of dexamethasone being developed for lumbar radicular pain to address the safety, efficacy and regulatory deficiencies of existing drugs available for epidural steroid injections, enabling patients and physicians to avail ultra-high concentration injections of sustained-release formulations.
Contact Information
Website
www.frenellepharma.comCorporate Office
- 15600 Medina Road
- Suite 147
- Plymouth, MN 55447
- United States
Corporate Office
- 15600 Medina Road
- Suite 147
- Plymouth, MN 55447
- United States
Frenelle Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 21-Oct-2021 | $1.22M | Completed | Generating Revenue | ||
| 6. Grant | 01-Jun-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B2) | 28-Aug-2018 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B2) | 28-Feb-2018 | Completed | Generating Revenue | |||
| 3. Grant | 31-Dec-2017 | Completed | Generating Revenue | |||
| 2. Grant | 10-Mar-2017 | $2.19M | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2015 | $225K | Completed |
Frenelle Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B-2 | ||||||||
| Series B-1 | 907,241 | $0.001000 | 8% | $0.7 | $0.7 | 1x | $0.7 | 4.86% |
| Series A | 1,872,858 | $0.001000 | 8% | $0.35 | $0.35 | 1x | $0.35 | 10.03% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Frenelle Pharma Comparisons
Industry
Financing
Details
Frenelle Pharma Competitors (8)
One of Frenelle Pharma’s 8 competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Relmada Therapeutics | Formerly VC-backed | Coral Gables, FL | ||||
| InterAx | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Nocion Therapeutics | Venture Capital-Backed | Watertown, MA | ||||
| Semnur Pharmaceuticals | Formerly VC-backed | Palo Alto, CA |
Frenelle Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Frenelle Pharma Patents
Frenelle Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2019533716-A | Pharmaceutical composition and use thereof | Active | 28-Oct-2016 | ||
| JP-6712003-B2 | Pharmaceutical composition and use thereof | Active | 28-Oct-2016 | ||
| AU-2016428204-A1 | Pharmaceutical compositions and uses thereof | Active | 28-Oct-2016 | ||
| AU-2016428204-B2 | Pharmaceutical compositions and uses thereof | Active | 28-Oct-2016 | ||
| CA-3042009-A1 | Pharmaceutical compositions and uses thereof | Active | 28-Oct-2016 | A61K31/573 |
Frenelle Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Frenelle Pharma Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Knoa Pharma | Corporation | Minority | ||
| United States Department of War | Government | |||
| National Institutes of Health | Government | |||
| United States Army | Government | |||
| U.S. Department of Health and Human Services | Government |
Frenelle Pharma FAQs
-
When was Frenelle Pharma founded?
Frenelle Pharma was founded in 2011.
-
Where is Frenelle Pharma headquartered?
Frenelle Pharma is headquartered in Plymouth, MN.
-
What is the size of Frenelle Pharma?
Frenelle Pharma has 8 total employees.
-
What industry is Frenelle Pharma in?
Frenelle Pharma’s primary industry is Drug Discovery.
-
Is Frenelle Pharma a private or public company?
Frenelle Pharma is a Private company.
-
What is the current valuation of Frenelle Pharma?
The current valuation of Frenelle Pharma is .
-
What is Frenelle Pharma’s current revenue?
The current revenue for Frenelle Pharma is .
-
How much funding has Frenelle Pharma raised over time?
Frenelle Pharma has raised $19.4M.
-
Who are Frenelle Pharma’s investors?
Knoa Pharma, United States Department of War, National Institutes of Health, United States Army, and U.S. Department of Health and Human Services have invested in Frenelle Pharma.
-
Who are Frenelle Pharma’s competitors?
Centrexion Therapeutics, Relmada Therapeutics, InterAx, Nocion Therapeutics, and Semnur Pharmaceuticals are some of the 8 competitors of Frenelle Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
